Imagine a world without cancer.
The two main categories of lung cancer are small-cell lung cancer, and non-small-cell lung cancer, says Russell K. Hales, M.D. “Non-small cell lung cancer is… Read More »What are the different types of lung cancer? Is one more serious than the other?
“It's not just smoking that leads to lung cancer,” says Russell K. Hales, M.D. “ We know that environmental exposures and underlying lung disease can… Read More »I was diagnosed with restrictive lung disease. My mother and my cat died of lung cancer. I’m a non-smoker but worried about environmental issues. How likely is it that this will become lung cancer, and what would the treatment be?
“Not everything that arises in the lung is cancer,” says Russell K. Hales, M.D., a radiation oncologist, at the Johns Hopkins Kimmel Cancer Center on… Read More »What is ground glass opacity on the lung? Is it likely to be cancer and how do you determine whether it is or not?
A rare cell line developed by Johns Hopkins researchers is giving scientists their first chance in decades to test new therapies for a lethal pediatric… Read More »Two Studies Uncover Potential Treatments for Lethal Pediatric Brain Cancer DIPG
--This post was written by freelance writer Becky Ham. A compound made from the tree’s bark shows promise against tumors spurred by the leptin hormone.… Read More »Can Magnolia Help Break the Link Between Obesity and Breast Cancer?
Julie Brahmer, M.D., director of the Thoracic Oncology Program, began treating patients with immunotherapy drugs nearly a decade ago. She led one of the first… Read More »Side effects of immunotherapy: what to look for and when?
Tom Smith, M.D., wants cancer patients to live well. Fewer side effects, better quality of life, more joyful time with family…these are among the primary… Read More »Palliative medicine focus at #ASCO16 meeting
Immunotherapy expert, Suzanne Topalian, M.D., delivered a presentation to a standing room only crowd at the 2016 American Society of Clinical Oncology (#ASCO16) regarding new… Read More »Can biomarkers predict patients’ response to immunotherapy?
With recent FDA approvals of immunotherapy drugs for kidney and bladder cancer, patients now have more options to consider among their treatments. The 2016 ASCO… Read More »ASCO annual meeting features clinical trial results of immunotherapy for bladder and kidney cancer
A new immunotherapy drug -- the first in its class -- was approved by the Food and Drug Administration last week for bladder cancer. We… Read More »New immunotherapy drug approved to treat bladder cancer